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Abstract
Background: Maternal morbidity is a complex entity and its presentation and severity are on a spectrum. This
paper describes the conceptualization and development of a definition for maternal morbidity, and the framework
for its measurement: the maternal morbidity matrix, which is the foundation for measuring maternal morbidity,
thus, the assessment tool.
Discussion: We define maternal morbidity and associated disability as “any health condition attributed to and/or
complicating pregnancy and childbirth that has a negative impact on the woman’s wellbeing and/or functioning.” A
matrix of 121 conditions was generated through expert meetings, review of the International Classification of
Diseases and related health problems (ICD-10), literature reviews, applying the definition of maternal morbidity and
a cut-off of >0.1 % prevalence. This matrix has three dimensions: identified morbidity category, reported
functioning impact and maternal history. The identification criteria for morbidity include 58 symptoms, 29 signs, 44
investigations and 35 management strategies; these criteria are aimed at recognizing the medical condition, or the
functional impact/disability component that will capture the negative impact experienced by the woman.
Summary: The maternal morbidity matrix is a practical framework for assessing maternal morbidity beyond near-
miss. In light of the emerging attention to Universal Health Coverage (UHC) as part of the post-2015 Sustainable
Development Goals (SDGs) planning, a definition and standard identification criteria are essential to measuring its
extent and impact.
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Background
Improving maternal health and reducing related mortal-
ity have been key concerns of the international commu-
nity as one of the eight Millennium Development Goals
(MDG 5) [1]. However, maternal mortality accounts for
only a small fraction of the overall burden of poor ma-
ternal health. Maternal morbidity – the health problems
borne by women during pregnancy, childbirth and the
postpartum period contribute to this burden. Yet, the
true extent of maternal morbidity is unknown. It has
been suggested that for each maternal death, 20 or 30
women suffer from morbidity; however, these calcula-
tions are not based on standard, well documented, and
transparent methodologies [2, 3]. Overall, three major is-
sues have limited valid, routine, and comparable mea-
surements of maternal morbidity, the lack of a common
definition and identification criteria, standardized assess-
ment tools especially at primary health care level, and
common indicators to measure morbidity [2]. Develop-
ing measurement criteria for the burden of pregnancy
and post-partum related morbidity is crucial to the on-
going elaboration of the post-2015 Sustainable Deve-
lopment Goals (SDGs) in light of required attention to
morbidity as maternal deaths have dropped significantly
over the past two decades [4].
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In 2011, the World Health Organization (WHO) de-
veloped a common definition and identification criteria
for very severe cases of maternal morbidity (maternal
near-miss) allowing its routine measurement and moni-
toring, especially as a tool for assessment of the quality
of care women with severe morbidity receive [5]. Such
definition and criteria do not exist for less-severe cases
along the continuum of maternal ill health. It is neces-
sary to arrive at a common definition and to establish
clear criteria for accurate and routine measurement of
maternal morbidity in order to inform policy decisions,
resource allocation and ultimately to launch an appro-
priate programmatic response that will also help in redu-
cing maternal deaths, and long-term suffering and
disability. This is particularly essential at the community
and primary care levels, where most of the burden of
maternal morbidity is believed to be reported [6, 7], yet
instruments to quantify and measure it are currently
lacking [2].
To fulfill the need to measure and respond to the full
burden of maternal morbidity, WHO initiated a project,
funded by the Bill and Melinda Gates Foundation, to im-
prove the scientific basis for defining, measuring and
monitoring maternal morbidity. This project aims to
construct a definition and develop identification criteria
for maternal morbidity, estimate the burden of individ-
ual causes or determining factors of maternal morbidity
based on existing evidence, develop and test an assess-
ment tool for measuring maternal morbidity in low- and
middle-income countries, and develop indicators for ma-
ternal morbidity.
The project is led and carried out by a technical work-
ing group, the Maternal Morbidity Working Group
(MMWG), composed of obstetricians, physicians, mid-
wives, epidemiologists, medical anthropologists, public
health professionals and patient advocates from high-,
middle- and low-income countries [2]. The WHO
MMWG was initially convened in April 2012. Partici-
pants were invited to join the working group based upon
their known technical expertise in quantitative and
qualitative maternal health research, maternal health
programs, contributions to other related research initia-
tives or membership on WHO technical advisory groups
or with potential links to this work, consumer perspec-
tive, and to ensure regional and gender balance. Where
this paper reports decisions by the MMWG, these
were made by consensus discussions during five WG
meetings (April and August 2012, February 2013,
February and October 2014) as well as interim elec-
tronic communication.
Since 2012, the MMWG has elaborated on maternal
morbidity from different perspectives, and on the basis
of existing evidence has agreed on a common framework
for maternal morbidity. This body of work is intended to
complement the maternal near-miss morbidity concept,
whereby together they specify the full continuum of
maternal morbidity [2]. This work will be incorpo-
rated in the 11th revision of the key standards for
health conditions - the International Statistical Classi-
fication of Diseases and related health problems
(ICD), further enhancing the sustainability of the out-
puts [8]. While doing so, publishing the development
process to ensure transparency and encouraging fur-
ther collaboration from researchers, clinicians, and
other stakeholders have been key to the work of the
MMWG.
The objective of this paper is to describe this con-
cept, and the framework, for identifying and measur-
ing “non-severe” maternal morbidity, and the
maternal morbidity matrix (see Figs. 1 2, 3 and 4)
which informed the development of a “morbidity”
tool, which will be pilot tested for usability, feasibility,
and fit for purpose (Please see Table 1 for an outline
of the tool’s components). The "morbidity" tool is
conceptualized to measure maternal morbidity in pri-
mary health care settings which have high levels of
service demand [9]. Nonetheless, improved access is
not enough, health services must also be of good
quality [10]. Measuring morbidity can serve as an in-
dicator of the quality of obstetric care [11, 12]. Ideally
the long-term outputs of this project are to establish
routine data collection on maternal morbidity to
inform service provision at facility-level.
The MMWG deliberated the development of a
community (non-health care setting) level tool to cap-
ture women who do not have regular access to med-
ical services; however, given the time and resource
constraints as well as consideration of prior research
which found that women’s recall of complications has
low specificity and would necessitate observation by a
trained health or community worker [13, 14] the
Group chose to focus its efforts on the primary facil-
ity/lowest facility level point-of-care. We discuss the
development of the concept, the components of the
matrix and the theoretical and methodological under-
pinnings for each.
Discussion
Concept of maternal morbidity: rationale
A standard definition for maternal morbidity does not
exist nor does the literature report maternal morbidity
systematically in a commonly agreed upon approach [3].
On the basis of the background scoping exercise [3], and
building upon the WHO definition of health [15] and
maternal mortality [16], the MMWG, by consensus,
agreed on the definition for maternal morbidity and as-
sociated disability as “any health condition attributed to
and/or complicating pregnancy and childbirth that has a
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negative impact on the woman’s wellbeing and/or func-
tioning.” Heretofore, the term ‘maternal morbidity’ refers
specifically to this definition of the concept. This broad
definition recognizes the impact that morbidity may
have on different dimensions of health, beyond physical
health and seeks to encompass the totality of a woman’s
Fig. 1 Maternal morbidity matrix, Dimension 1: SYMPTOM, SIGN, INVESTIGATIONS & MANAGEMENT (Direct Maternal Morbidity)
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Fig. 2 Maternal morbidity matrix, Dimension 1: SYMPTOM, SIGN, INVESTIGATIONS & MANAGEMENT (Indirect Maternal Morbidity)
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sense of wellbeing. Terminology used in this manuscript
can be found in Table 2 below.
Based on this definition and with the goal of devel-
oping identification criteria to be embedded within a
measurement tool for maternal morbidity, we initially
focused on formulating and populating a matrix of
conditions, not limited by the obstetrical and
gynecological perspective. A number of issues were
identified by the MMWG to inform the basic premises
of the matrix, which members deemed necessary to in-
clude or at least consider for inclusion: 1) obstetric
morbidities, 2) previous/co-existing conditions, 3)
mental conditions, 4) intervention related morbidities,
5) trauma (i.e. domestic violence), and 6) cultural prac-
tices (i.e. female genital mutilation). In order to iden-
tify cases of maternal morbidity according to the
agreed upon definition and to strike a balance between
feasibility and utility in identification of maternal mor-
bidity cases, we adopted a set of guiding principles to
proceed with this work:
1) identification and measurement of the selected
maternal conditions should be pragmatic, action
oriented, evidence-based, feasible and applicable to
different settings, with regional and international
acceptance;
2) maternal morbidity should not be viewed as
consisting only of the conditions themselves, but
also their consequences; and
3) morbid conditions should be prioritized on the basis
of their frequency and impact. In addition, we may
focus on under- researched and neglected areas.
Balancing the tension between goals of being com-
prehensive and complete with usability and feasibility
proved to be a challenge considering issues such as
regional differences in disease incidence and preva-
lence, the spectrum of maternal morbidity, its occur-
rence, severity, duration, impact and how a morbidity
affects the woman’s well-being. To focus on “what to
measure”, we considered the role of prevalence and
impact, while recognizing the need to better under-
stand under-researched or neglected areas and the
need to define what is intended by the qualifiers of
“attributed to” or “complicating”. On “how to meas-
ure” maternal morbidity, we envisioned the develop-
ment of a core module applicable to primary care
settings. In either instance, the condition should be
associated with a negative maternal outcome. We spe-
cified that the particular areas of interest would be
the complications and/or manifestations of these con-
ditions either during pregnancy or postpartum.
Fig. 3 Maternal morbidity matrix, Dimension 2: Functional Impact - International Classification for Functioning and Disability (ICF) codes
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Maternal morbidity matrix: foundations of a
measurement tool
To devise identification criteria we considered catego-
rization of different markers anatomically or by system, as
was done in the development of maternal near-miss con-
cept. However, given the particularities of less-severe
pregnancy related complications, a more holistic
approach was favored. Unlike maternal near-miss
events, which have by definition very specific clinical,
laboratory and management markers, it was under-
stood that such markers might not be sufficient
enough to identify maternal morbidity [5, 11]. As
such, the maternal morbidity matrix consists of three
dimensions (Figs. 1 2, 3 and 4).
Similar to the near-miss criteria, we sought to de-
velop a set of locally relevant criteria which allow for
comparisons between different settings, regions and
countries. Therefore, the first dimension consists of the
symptoms, signs, investigations and management strat-
egies. Unlike near-miss, symptoms are included in the
identification criteria of maternal morbidity, with the
anticipation that they would correlate strongly with the
associated disability (e.g. fatigue, shortness of breath)
and thus, may be the primary reason for women to seek
care. Signs are findings on physical examination and
are similar to the clinical criteria of the near-miss
criteria. The identification criteria also include investi-
gations, which are broader in scope than the lab
markers for the near-miss criteria, and are comprised
Fig. 4 Maternal morbidity matrix, Dimension 3: Maternal History
Table 1 Maternal morbidity draft tool components
Section 1: Personal history Social and demographic information
Obstetric history ( focusing on current/
most recent pregnancy)
Sexual Health
Risk-factors/environment
Section 2: Symptoms Disability and functioning
−WHO Disability Assessment
Schedule 2.0 (12-item version)
General symptoms
Mental health
−Generalized Anxiety Disorders-7
−Personal Health Questionnaire −9
Section 3: Signs General physical exam
Laboratory tests and results
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of laboratory tests, imaging studies and diagnostic tests
such as biopsies. Management strategies include treat-
ment options like medications, surgical procedures and
radiation.
Initially, the Group aimed to make the matrix as com-
prehensive as possible, representing both developing and
developed country settings. Informed by the WHO
scoping exercise on maternal morbidity [3], reviews of
published literature, relevant textbooks and the WHO
Application of ICD-10 to deaths during pregnancy,
childbirth and the puerperium: ICD-Maternal Mortality
(ICD-MM) [17], a set of conditions were selected. We
considered conditions that may occur in women of re-
productive age including those specific to pregnancy and
postpartum. A matrix was developed, including each of
these conditions and their relevant symptoms, signs, in-
vestigations and management strategies. The first ver-
sion included 301 conditions, originally cross-referenced
with 109 symptoms, 106 signs, 121 clinical tests and 91
management strategies [2]. At this point, the MMWG
recognized the existing health care structures in low-
and middle-income countries (LMICs) to balance aspir-
ational versus pragmatic approaches. Therefore, to fur-
ther consolidate the matrix, the Group developed and
agreed up the following criteria:
1) conditions associated with a negative maternal
outcome that are either exclusive to pregnancy,
childbirth, and the postpartum state, with an
estimated occurrence of >0.1 % in pregnancy; or
2) conditions that are not exclusive to pregnancy,
childbirth, and postpartum but which occur more
frequently during pregnancy (i.e. pregnancy is a risk
factor for the disease).
The cut-off of 0.1 % for occurrence (prevalence or in-
cidence) was deemed to be a reasonable cut-off that
distinguished between very rare diseases and diseases
that are more common and was informed by current es-
timates of disease conditions in the published literature.
When evidence was unavailable, the group used a con-
sensus mechanism based on expert opinion. Addition-
ally, to account for regional differences in prevalence of
certain conditions, the Group intends for the tool, based
on the matrix, to be revised for regional implementation.
Moreover, to frame the matrix we used the precedent
of ICD-MM, a special adaption of the ICD-10 intended
to improve the classification of maternal mortality and
morbidity [11, 17]. We grouped the domains in line with
the ICD-MM, such as pregnancies with abortive out-
come, obstetric hemorrhage or non-obstetric complica-
tions, with the intent of showing how data at different
levels of detail may be aggregated together and to ensure
continuity between the spectrum of morbidity through
mortality [17]. Additionally, though it is beyond the
scope of this work to revisit the definition of “direct”
and “indirect” maternal mortality (and by extension,
morbidity); the work of this group in reviewing the con-
ditions aligned to each category has been informing the
discussion on whether the distinction between “direct” and
“indirect” remain necessary or useful. As a result of the
abovementioned process, the next version of the matrix in-
cludes 121 conditions cross-referenced with all identified
criteria based on the ICD-MM groupings and generated 58
symptoms, 29 signs, 44 investigations and 35 management
strategies. Conditions consistent with severe maternal mor-
bidity as manifestations of maternal near-miss were not in-
cluded in this consolidated matrix as they are already
identified by the maternal near-miss tool [11].
A second dimension is the functional impact and dis-
ability assessing the loss of physical, psychological, cog-
nitive, social and economic functions. Key concepts
related to functioning and disability as conceptualized
and defined in the International Classification of
Table 2 Definitions
Term Definition
Maternal Death The death of a woman while pregnant or within 42 days of termination of pregnancy, irrespective of the duration
and the site of the pregnancy, from any cause related to or aggravated by the pregnancy or its management, but
not from accidental or incidental causes [17]
Maternal Near-Miss A woman who nearly died but survived a complication a complication that occurred during pregnancy, childbirth
or within 42 days of termination of pregnancy [11]. Signs of organ dysfunction that follow life-threatening
conditions are used to identify maternal near-misses and a set of near-miss indicators enables assessments of the
quality of care provided to pregnant women [5].
Maternal morbidity and
associated disability
Any health condition attributed to and/or complicating pregnancy and childbirth that has a negative impact on
woman’s wellbeing and/or functioning.
Functioning Is an umbrella term for body functions, structures, activities and participation. It denotes the negative aspects of
the interaction between an individual (with a health condition) and that individual’s contextual factors
(environmental and personal factors) [29].
Disability Is an umbrella term for impairments, activity limitations and participation restrictions. It denotes the negative
aspects of the interaction between an individual (with a health condition) and that individual’s contextual factors
(environmental and personal factors) [29].
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Functioning, Disability and Health (ICF) are incorpo-
rated [11] thru the existing, validated tool, WHO Dis-
ability Assessment Schedule 2.0 (WHODAS 2.0) [18].
This tool covers 6 domains in line with ICF (cognition,
mobility, self-care, getting along, life activities and par-
ticipation) and produces standardized disability levels
and profiles using a short, simple and easy to administer
questionnaire [18]. In addition, preliminary findings
from a systematic review on maternal morbidity and
quality of life, currently in progress, will be used to re-
fine our assessment tool to be more centered on mater-
nal health to gauge women’s experiences.
The third dimension is the maternal history focusing on
social and health related characteristics, which might help
identify the maternal morbidity as well as influence the
risk and severity of the morbidity. Some examples include
socio-economic determinants, pre-existing conditions,
care seeking during the pregnancy, etc. Incorporating ma-
ternal demographic characteristics, past obstetric history,
history during index pregnancy and fetal outcome allows
full elaboration of the “woman as a whole”. Inclusion of
fetal measures in the index pregnancy appraises linkages
between maternal morbidity and fetal outcomes, attesting
to the irrefutable mother-baby dyad.
Conclusions
Time is now: implications and next steps
This body of work elaborates the first standard global
definition and classification of maternal morbidity. The
epidemiology of pregnancy and childbirth reflects chan-
ging demographic patterns; the latest global estimates on
causes of maternal deaths demonstrate the increased
role of indirect conditions in causing maternal deaths
[19]. Moreover, as described in the “obstetric transition
model”, with declining maternal deaths, the proportion
of individuals with morbidities can only be expected to
rise [20]. Beyond documenting known contributors to
this changing epidemiology, e.g. the increased age at
which women become pregnant [21] and co-morbidities
such as obesity [22], this framework puts the focus on
the women and incorporates the concepts related to dis-
ability and functioning.
Based on this concept and framework, we are in the
process of developing and testing a modular set of ma-
ternal morbidity assessment tools in three country set-
tings. This tool will have different modules depending
on the time of data collection (antenatal and postnatal).
The assessment tools were designed based on the matrix
by thorough iterations and expert review. Whenever
possible, previously validated tools and scales were
employed and adapted. For example, established sexual
dysfunction and mental health scales are employed as
part of the 1st dimension, the WHODAS 12-item ver-
sion as part of the 2nd dimension and substance abuse
and intimate partner violence scales as part of the 3rd
dimension [18, 23]. The results of pilot testing will direct
further refinement and development of the maternal
morbidity tool to ascertain the potential need for re-
gional or country level modifications and to determine
its utility in identifying morbidities and issues related to
implementation of the tool. Given the paucity of data on
disability from LMICs and poorer resourced areas, the
interpretation of these pilots will be critical. In the fu-
ture, this framework can inform a probabilistic algorithm
like the Interpreting Severe Acute Maternal Morbidity
(InterSAMM) to identify morbidity, which was in turn
modeled after the Interpreting Verbal Autopsy - 4
(InterVA-4) to identify cause of death [24–26].
By identifying a case of maternal morbidity, either via
an identified morbidity category and/or by documenta-
tion of an associated disability, we believe that the data
collected by the assessment tools will have sufficient
granularity and allow for disaggregation to understand
what is the incidence/prevalence of a particular morbid-
ity category, and what is the incidence/prevalence of the
associated disability according to the women. Both
count. In this regard, this work also coincides with the
ongoing revision of the ICD. The theoretical need to
“count” morbidities or clinical conditions and the
women-reported outcomes inform the broader discus-
sion of trying to understand what we measure and why.
Such discourse is particularly important as the global
community debates the post-2015, Sustainable Develop-
ment Goals (SDGs) agenda, with special attention to
universal health coverage (UHC) as an important aspect
to improve health and contribute to development of
populations [27]. With regard to maternal health post-
2015 goal and targets, the underlying strategies towards
the Ending Preventable Maternal Mortality (EPMM) are
intended to address the overall health needs of girls and
women [28]. Articulated within the strategic objectives
towards EPMM is the need “to address all causes of ma-
ternal mortality, reproductive and maternal morbidities,
and related disabilities” and to ensure UHC for accessing
care [28]. This is based upon the premise that improved
information on morbidity and its lasting consequences,
is also likely to expose the inter-related nature of preg-
nancy care to other aspects of the health sector as well
as non-health sectors (e.g. environment, transportation,
financing). Its most important contribution will be, how-
ever, in enhancing health system response to maternal
morbidity, including strengthening evidence for the de-
termination of packages for UHC, key means to improve
access to health care and improve health of populations.
Development of a standard definition and framework
for maternal morbidity is rife with challenges and the
maternal morbidity matrix is a practical framework for
assessing maternal morbidity beyond near-miss. In light
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of the emerging attention to UHC as part of the post-
2015 SDGs planning, a definition and standard identifi-
cation criteria are essential to measuring its extent and
impact. As the international community looks at the de-
creases in maternal mortality, there is an urgent tandem
need to define and measure maternal morbidity. Looking
beyond 2015, this is an investment we cannot afford to
ignore.
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